PHARMIMPULSE
The computed 12-month bankruptcy probability of PHARMIMPULSE is 0.2% (very low). The company has been active since 2015 and the Belgian State Gazette contains no insolvency or warning signals. No processed annual-account figures are available; this conclusion rests on registry and State Gazette data only.
| Active | 10 yrs |
| Locations | 1 |
| Publications | 1 |
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
| Fiscal year | Type | Filed | Reference |
|---|---|---|---|
| 31-12-2024 | micro | 21-10-2025 | 2025-00547464 |
| 31-12-2022 | micro | 25-12-2023 | 2023-00538485 |
| 31-12-2021 | volledig | 31-08-2022 | 2022-20404961 |
| 31-12-2020 | volledig | 30-09-2021 | 2021-70100014 |
| 31-12-2019 | volledig | 30-10-2020 | 2020-66100485 |
| 31-12-2018 | volledig | 27-08-2019 | 2019-52800188 |
| 31-12-2017 | volledig | 30-08-2018 | 2018-54500548 |
| 31-12-2016 | volledig | 25-08-2017 | 2017-47700348 |
| NACE primary | 78200 |
| Legal form | General partnership(011) |
| Incorporation | 11-08-2015 |
| Status | Active |
| Postal code | 1380 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 25087C0102/00R000 | Wallonia | 2,122 m² | 1 · 109 m² | 6.7 m · 1 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
28-01-2025 Paul RANSART reappointed as director (executive)
- Paul RANSART, Directeur
Technical details
{
"events": [
{
"kind": "director_renew",
"role": "directeur",
"person": {
"rrn": null,
"name": "Paul RANSART",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": "renewal",
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": "2021-06-30",
"evidence_quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale d\u00E9cide d\u00E8s lors de ratifier, avec effet r\u00E9troactif, tous les actes qui ont \u00E9t\u00E9 pos\u00E9s depuis le 30 juin 2021",
"decharge_status": null,
"mandate_duration": {
"kind": "until_agm_year",
"value": "2027"
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": "retroactive"
}
],
"notary": {
"name": null,
"firm_city": null,
"firm_name": null,
"office_city": "Genappe",
"is_associated": false
},
"act_meta": {
"language": "mixed",
"pub_date": "2025-01-28",
"filing_date": "2025-01-17",
"act_kind_objet": "Objet de l\u0027acte:"
},
"decisions": [
{
"body": "buitengewone_algemene_vergadering",
"date": "2024-07-11",
"unanimous": true
}
],
"is_correction": false,
"subject_company": {
"kbo": "0634.979.024",
"name_full": "PHARMIMPULSE",
"legal_form": "G.I.E."
},
"publication_proxy": {
"kind": "none",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [],
"corrected_publication_numac": null
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameFR | PHARMIMPULSE |